Current Treatment Options in Neurology

Papers
(The TQCC of Current Treatment Options in Neurology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Genetic Testing for Epilepsy: A User Guide46
Education and Team Science in Neurocritical Care44
Treatment of Symptomatic Carotid Webs: Current Evidence and Future Directions29
Continuous EEG in Day to Day Neurocritical Care – A Case Based Review28
Reducing Sudden Unexpected Death in Epilepsy: Considering Risk Factors, Pathophysiology and Strategies27
Tau in Multiple Sclerosis: A Review of Therapeutic Potential23
Updates in the Management of Neuromuscular Emergencies20
Should we Treat Sleep Apnoea to Prevent Dementia?18
Speech Language Pathology in the Neurocritical Care Unit11
Treatment of Vascular Myelopathies11
Efficacy and Safety of Atogepant for Preventing Chronic and Episodic Migraines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials11
Correction to: Diagnosis and Management of Progressive Corticobasal Syndrome9
Treatment of Malignant Cerebral Edema in Acute Ischemic Stroke9
Addressing the Burden of Pathological Fatigue in Stroke Survivors: A Review of Present and Potential Non-Pharmacological and Pharmacotherapeutic Options9
Biomarker Defined Acute Optic Neuritis: A Review and Perspective7
Ocular Myasthenia Gravis7
Correction to: Gut Microbiome as Potential Therapeutics in Multiple Sclerosis6
Updates in the Management of Cervical Artery Dissections5
Diagnosis and Treatment of Poststroke Epilepsy: Where Do We Stand?5
Treatment of Fever in Neurologically Critically Ill Patients5
Epilepsy Management in Transgender and Gender Diverse People5
Managing the Behavioral and Psychological Symptoms of Dementia5
Headache as a Neurologic Manifestation of Systemic Disease4
Clinical Trial Outcome Measurements in Lennox-Gastaut Syndrome and Their Application to the Development of Targeted Treatments4
Management Strategies for Atypical Parkinsonism4
Updates on Facioscapulohumeral Muscular Dystrophy (FSHD)4
Predicting and Treating Post-traumatic Epilepsy4
The A2F ICU Liberation Bundle in Neurocritical Care4
Mechanical Thrombectomy for Acute Ischemic Stroke: Current State and Future Directions3
Clinical Applications of Non-Invasive Brain Stimulation in Stroke Recovery: A Review of Current Evidence and Therapeutic Strategies3
Diagnosis, Treatment, and Prevention of Stroke in Transgender Adults3
Correction to: Acute Stroke Treatment in Children: Are Adult Guidelines Applicable?3
Update on Treatment of Idiopathic (and Non-Idiopathic) Orbital Inflammation3
Update on Stroke Prevention and Treatment in Patients with Antiphospholipid Antibody Syndrome3
Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy3
Key Treatment Issues for Epilepsy in the Context of Autism Spectrum Disorder3
Seizures in the Setting of COVID-193
Dual Antiplatelet Therapy in Ischemic Stroke Prevention: Which Two Could Be Better than One?3
Strategic De-escalation of Disease-Modifying Therapies in Elderly Patients: Approaches and Considerations3
Vaccine Based Approaches for the Prevention and Treatment of Neurological Disease3
Treatment Approaches in Pediatric Relapsing Autoimmune Encephalitis3
Approach to the Management of Sodium Disorders in the Neuro Critical Care Unit3
0.14482998847961